Domus Diagnostics develops low-cost, high-accuracy diagnostic tests for infectious diseases using proprietary RT-LAMP one-step, one-temperature technology. Their solutions are designed for simplicity and rapid results across various settings, including at-home, point-of-care clinics, and central laboratories. This novel chemistry and manufacturing approach enables ultra-low-cost nucleic acid testing that achieves laboratory PCR-level accuracy.
Funding
$2.4M raised to dateRaised to date based on public sources. This may differ from the amount the company actually raised and is based only on what is publicly available on the internet.
Founders
Product
Problem
Current laboratory-based PCR tests for respiratory diseases are expensive, time-consuming, and require specialized equipment and trained personnel. This limits accessibility, especially for at-home use and in resource-constrained settings, hindering rapid diagnosis and timely intervention.
Solution
Domus Diagnostics is developing a rapid, low-cost, and highly accurate diagnostic platform for respiratory diseases based on a proprietary RT-LAMP one-step, one-temperature technology. This platform enables point-of-care and at-home testing with performance comparable to laboratory PCR tests. The tests are designed to be simple to use, disposable, and provide results in under 30 minutes, facilitating widespread adoption across various settings, including homes, clinics, and central laboratories. The company's technology combines custom chemistry with simplified manufacturing to achieve ultra-low-cost solutions.
Target Audience
The primary target audience includes individuals seeking at-home testing solutions, clinics requiring point-of-care diagnostics, and central laboratories aiming to reduce testing costs.
Features
- Proprietary RT-LAMP one-step, one-temperature technology for nucleic acid amplification
- Disposable, no-electricity home-resulting test
- Rapid results in 30 minutes or less
- High accuracy: >95% sensitivity and 100% specificity
- Potential for adaptation to desktop instruments for clinics and dedicated assays for established analyzer platforms in central laboratories
- Simple and intuitive design for use across languages, education levels, and disabilities